NCT02697786

Brief Summary

Postoperative brain damage and neuropsychological disorders have been observed in 30 - 80 % of patients after heart surgery with the use of cardiopulmonary bypass (CPB).They can persist up to a year after cardiac surgery and are associated with increased hospital mortality and prolonged intrahospital stay. Hypoperfusion,hyperthermia,atrial fibrillation,genetic predisposition and systemic inflammatory response associated with CPB have been identified as pathophysiological mechanisms.However, some authors consider cerebral embolisation to be the prevalent mechanism of intraoperative brain injury after cardiac surgery,as gaseous or solid cerebral emboli can cause ischemia, inflammation and edema,consequently causing cerebral infarctions usually resulting with stroke,coma,encephalopathy, delirium and cognitive decline. Additionally,they may impair cerebrovascular reactivity (CVR). Aortic valve replacement (AVR) preformed by full sternotomy is the standard approach in the treatment of aortic valve disease. Minimally invasive (MIS) aortic valve replacement has been shown to reduce postoperative mortality, morbidity, and pain while providing faster recovery, a shorter hospital stay, and better cosmetic results. However, due to technically more demanding procedure, MIS may lead to prolonged CPB time and incomplete de-airing of the heart with an increased risk for cerebral gas embolization. Therefore, the choice of MIS might bear an augmented risk for brain injury. Transcranial Doppler (TCD) enables real time detection of intraoperative emboli in the cerebral arteries seen as microembolic signals (MES), and is an essential neuromonitoring tool. Several studies demonstrated correlation between the number of MES and the occurrence as well as severity of postoperative neurological complications. However, the factors contributing to brain injury have not been elucidated in those studies. The investigators speculate that impairment of CVR is an important mechanism that persists and prolongs the duration of brain injury into postoperative period. The aim of the study is to compare two surgical approaches used for AVR, with focus on the number of MES and their impact on levels of protein S100B (marker of brain tissue damage),postoperative CVR and cognitive function With the results,the investigators aim to help surgeons in selecting the appropriate technique for AVR in individual participants,as well as to clarify the effect of aortic valve surgery on the brain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2016

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2016

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 25, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

March 3, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

October 28, 2016

Status Verified

October 1, 2016

Enrollment Period

1.9 years

First QC Date

January 25, 2016

Last Update Submit

October 27, 2016

Conditions

Keywords

Aortic valve surgery

Outcome Measures

Primary Outcomes (3)

  • Detection of the intraoperative microembolic signals during minimal invasive sternotomy compared to full sternotomy with TCD during aortic valve surgery

    Intraoperative detection:Beginning of surgery, after sternotomy, during aortic cannulation, during CPB, during de-aeration, opening of the clamp on the aorta and after CBP removal before chest closure.

  • Detection of S100B serum protein, marker of brain tissue damage

    Before induction of anesthesia, 6 h , 24 h, 48h and 7 days after CPB

  • Detection of serum interleukin IL-1, IL-6,IL-8,Il-10 and Microparticles

    Before induction of anesthesia, 6 h , 24 h, 48h and 7 days after CPB

Secondary Outcomes (2)

  • Assessment of cerebrovascular reactivity using visually evoked cerebral blood flow velocity response (VEFR) measurements

    7 days before and 7 days after surgery

  • Assessment of neurologic and cognitive function in patients undergoing AVR

    7 days before and 7 days after surgery

Other Outcomes (4)

  • Length of ICU stay

    Post operative period, an expected average of 2 days

  • Requirement for inotropic and vasoactive therapy

    1)After induction of anesthesia, 2)at the end of CPB ,3) postoperative period

  • Duration of mechanical ventilation

    postoperative period, an expected average 2 days

  • +1 more other outcomes

Study Arms (2)

AVR preformed with full sternotomy

ACTIVE COMPARATOR

30 patients, 7 days before and after surgery mini mental test and measurement of visual evoked cerebral blood flow response (VEFR) will be done. Transcranial doppler measurements 1. beginning of the surgery, 2.after sternotomy, 3.during aortic cannulation,4.during CPB,5. during de-airing, 6. opening of the clamp on the aorta, 7. after CPB removal before chest closure. Prolonged de airing if needed

Device: Transcranial doppler

AVR preformed with minimal invasive sternotomy

EXPERIMENTAL

30 patients, 7 days before and after surgery mini mental test and measurement of visual evoked cerebral blood flow response (VEFR) will be done. Transcranial doppler measurements 1. beginning of the surgery, 2.after sternotomy, 3.during aortic cannulation,4.during CPB,5. during de-airing, 6. opening of the clamp on the aorta, 7. after CPB removal before chest closure. Prolonged de airing if needed

Device: Transcranial doppler

Interventions

Prolonged de airing to decrease the number of MES

AVR preformed with full sternotomyAVR preformed with minimal invasive sternotomy

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Isolated aortic valve stenosis as well as asymptomatic patients with depressed systolic function
  • Symptomatic patients with normal or depressed left ventricular function
  • Patients with American Society of Anesthesiologist (ASA) physical status classification 2 or 3

You may not qualify if:

  • History of brain stroke
  • EF less than 20%
  • History of alcohol abuse
  • Epilepsy of history of psychiatric illness and antipsychotic drugs
  • Patients with stenosis on carotid arteries
  • Patients with preformed surgery or already stented carotid arteries
  • Patients with poor or absent acoustic temporal window
  • Diagnosed dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Clinical center

Ljubljana, Ljubljana, 1000, Slovenia

Location

Related Publications (1)

  • Bozhinovska M, Jenko M, Stupica GT, Klokocovnik T, Ksela J, Jelenc M, Podbregar M, Fabjan A, Sostaric M. Cerebral microemboli in mini-sternotomy compared to mini- thoracotomy for aortic valve replacement: a cross sectional cohort study. J Cardiothorac Surg. 2021 May 24;16(1):142. doi: 10.1186/s13019-021-01509-8.

MeSH Terms

Conditions

Brain Injuries

Interventions

Ultrasonography, Doppler, Transcranial

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Intervention Hierarchy (Ancestors)

EchoencephalographyNeuroradiographyNeuroimagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographyUltrasonographyUltrasonography, DopplerDiagnostic Techniques, NeurologicalInvestigative Techniques

Study Officials

  • Maja Sostaric, MD, PhD

    University Medical Centre Ljubljana

    STUDY DIRECTOR
  • Matej Podbregar, MD, PhD

    University Medical Centre Ljubljana

    STUDY DIRECTOR
  • Tomislav Klokocovnik, MD,PhD

    University Medical Centre Ljubljana

    STUDY DIRECTOR
  • Borut Gersak, MD, PhD

    University Medical Centre Ljubljana

    STUDY DIRECTOR
  • Marija Bozhinovska, MD, MSc

    University Medical Centre Ljubljana

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, MSc, Spec.

Study Record Dates

First Submitted

January 25, 2016

First Posted

March 3, 2016

Study Start

January 1, 2016

Primary Completion

December 1, 2017

Study Completion

April 1, 2018

Last Updated

October 28, 2016

Record last verified: 2016-10

Locations